NCT05550636View on ClinicalTrials.gov

A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 11, 2022

Primary Completion Date

December 16, 2022

Study Completion Date

December 16, 2022

Conditions
Healthy
Interventions
DRUG

BI 1015550

BI 1015550

DRUG

midazolam

midazolam

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05550636 - A Study in Healthy Men to Test Whether BI 1015550 Influences the Amount of Midazolam in the Blood | Biotech Hunter | Biotech Hunter